David A Byron

Title: Innovations by David A Byron in Pulmonary Disease Treatment

Introduction

David A Byron is an accomplished inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary diseases. His innovative approach focuses on the administration of oxybutynin, a medication commonly used for various medical conditions.

Latest Patents

David A Byron holds a patent for "Methods and compositions for administration of oxybutynin." This invention is directed towards methods and compositions for treating pulmonary disease by delivering a therapeutically effective amount of oxybutynin directly to a patient's lungs. The patent outlines the use of oxybutynin in combination with one or more pharmaceutically effective agents, which may include bronchodilators, anti-inflammatories, corticosteroids, and other agents. He has 1 patent to his name.

Career Highlights

Byron is currently associated with Microdose Therapeutx, Inc., where he continues to work on innovative solutions for pulmonary diseases. His expertise and dedication to research have positioned him as a valuable asset in the medical field.

Collaborations

Throughout his career, David has collaborated with notable professionals, including Robert Owen Cook and Scott Fleming. These partnerships have contributed to the advancement of his research and the development of effective treatments.

Conclusion

David A Byron's work in the field of pulmonary disease treatment exemplifies the impact of innovation in medicine. His patent on oxybutynin administration showcases his commitment to improving patient care through scientific advancements.